Medlive Technology Co Sustainability Profile
Medlive Technology Co., a leading player in the healthcare technology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2015, the company has rapidly established itself as a pioneer in medical data solutions, telemedicine, and healthcare management systems. Medlive's core offerings include advanced medical imaging software and integrated health information platforms, designed to enhance clinical decision-making and improve patient outcomes. What sets Medlive apart is its commitment to innovation, leveraging cutting-edge technology to streamline healthcare processes. With a strong market position, Medlive Technology Co. has achieved significant milestones, including partnerships with major healthcare institutions and recognition for its contributions to digital health. The company continues to drive advancements in the industry, making healthcare more accessible and efficient for providers and patients alike.
DitchCarbon Score
How does Medlive Technology Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medlive Technology Co's score of 28 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medlive Technology Co's reported carbon emissions
In 2024, Medlive Technology Co., based in China (CN), reported total carbon emissions of approximately 753,783 kg CO2e. This figure comprises 47,061 kg CO2e from Scope 2 emissions and 706,722 kg CO2e from Scope 3 emissions, while Scope 1 emissions were recorded at zero. In comparison, the 2023 emissions data indicated a total of about 828,278 kg CO2e, with 60,102 kg CO2e from Scope 2 and 768,176 kg CO2e from Scope 3. Medlive has not set specific reduction targets or climate pledges, and there are no documented initiatives aimed at reducing emissions. The absence of Scope 1 emissions suggests a limited direct impact from their operations, while the significant Scope 2 and Scope 3 emissions highlight the importance of addressing indirect emissions in their climate strategy. Overall, Medlive Technology Co. is currently focused on understanding and managing its carbon footprint, particularly in relation to its Scope 2 and Scope 3 emissions, as it navigates the complexities of climate commitments within the technology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | - | - | - |
| Scope 2 | 67,396,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 000,000,000 |
How Carbon Intensive is Medlive Technology Co's Industry?
How Carbon Intensive is Medlive Technology Co's Location?
Medlive Technology Co's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medlive Technology Co has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
